Position in MRK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,516,942
+$117,007 QoQ
Shares Held
11,805
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,791
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Claro Advisors Inc. holds $23,719,798 across 11 Drug Manufacturers - General names. MRK ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,282 | $5,858,682 | |
| 2 | JNJ |
Johnson & Johnson
|
22,661 | $5,755,214 | |
| 3 | LLY |
ELI LILLY & Co
|
3,896 | $4,672,979 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
11,805 | $1,516,942 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,313 | $1,400,915 | |
| 6 | AMGN |
Amgen Inc
|
3,385 | $1,225,776 | |
| 7 | PFE |
Pfizer Inc
|
47,000 | $1,131,760 | |
| 8 | NVO |
Novo Nordisk A S
|
21,612 | $1,036,079 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,516,942 | 11,805 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,399,935 | 11,638 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,267,540 | 12,042 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,046,103 | 12,464 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,036,996 | 13,100 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,340,924 | 14,939 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,577,056 | 15,853 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,087,800 | 18,385 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,014,226 | 16,270 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,931,352 | 14,637 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,526,498 | 14,002 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,385,912 | 13,462 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,514,609 | 13,126 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,349,557 | 12,685 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,192,268 | 10,746 | Shares | Sole | 2023-03-13 | |
| 2022-09-30 | $711,178 | 8,258 | Shares | Sole | 2022-11-18 | |
| 2022-06-30 | $752,881 | 8,258 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $635,641 | 7,747 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $593,730 | 7,747 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $573,915 | 7,641 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $567,954 | 7,303 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $514,961 | 6,680 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $536,198 | 6,555 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $694,623 | 8,374 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $646,556 | 8,361 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $637,986 | 8,292 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||